Revolutionary ‘Bionic Pancreas’ Approved by FDA to Help Diabetics Manage Blood Sugar Levels with Ease

Type 1 diabetes is no match for this gymnast

The Food and Drug Administration (FDA) has recently approved a device for diabetics called the “bionic pancreas,” which can help alleviate the burden of constantly monitoring carbohydrate intake. This innovative device allows users to input the size of their next meal, and an AI algorithm determines the precise amount of insulin needed to maintain stable blood sugar levels. For 15-year-old Mia Campos, a skilled gymnast from San Antonio who has been living with type 1 diabetes for five years, this new technology has been life-changing.

Mia was diagnosed with diabetes during a gymnastics competition when she experienced symptoms like excessive thirst and frequent urination. She was fitted with a traditional insulin pump, which required constant programming and often experienced glitches. Fortunately, her pediatric endocrinologist recommended the “bionic pancreas,” which has now been cleared by the FDA for commercial use. Clipped to her jeans, the device uses AI software to tailor insulin delivery to her glucose levels.

The iLet device is suitable for use in individuals aged six and up and requires only one input regarding the size of the user’s next meal. The device then learns the user’s biorhythms and delivers insulin accordingly, keeping blood sugar levels stable. Mia is thrilled with the benefits of the device, allowing her to focus on her homework and gymnastics training rather than constantly worrying about her carb intake and insulin levels.

The “bionic pancreas” uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed. Dr. Lynch, Mia’s pediatric endocrinologist, emphasizes that diet and exercise are still critical components of managing blood sugar levels. Mia believes that this new technology will greatly benefit individuals, particularly children, who have busy lives and struggle to manually track their carb intake.

In conclusion, the “bionic pancreas” is a revolutionary device that has been approved by the FDA for commercial use. It allows diabetics to input their next meal size and receive personalized insulin delivery through an AI algorithm. This new technology has been life-changing for 15-year-old Mia Campos and is expected to benefit many others in similar situations.

Leave a Reply